AndroGel maker defends product in spite of heart attack, stroke and death risk

In spite of an increase in the risk of heart attack, stroke and death, the maker of AndroGel — AbbVie — defended its product recently, stating studies have shown that the testosterone supplement actually protects against metabolic syndrome and early death, according to a report from ABC News. This statement doesn’t match more recent studies, however, that show a dramatic increase in the likelihood of death within three years for men with low testosterone who used testosterone supplements.

According to Dr. Steven Nissen, chairman of cardiovascular medicine at Cleveland Clinic, the rampant use of testosterone replacement — often prompted by television advertisements that encourage men to ask their physicians about supplementing their testosterone — is concerning. Nissen is calling for the FDA to insist on large, controlled trials to determine the safety of testosterone replacements such as AndroGel.

The health effects of low testosterone in men include a decreased libido, lessened strength and lower energy levels. However, these problems can be caused by other issues, as well. It is imperative, the article states, for men who are experiencing these health effects to be fully tested in order to determine if low testosterone is, in fact, the cause of the problems. In addition, men are encouraged to discuss with their physicians and heavily weigh the risks of testosterone supplements. In addition to the increased likelihood of death, testosterone supplements have also been shown to cause an increased chance of heart attack and stroke.

If you or a loved one has suffered a serious health issue after using AndroGel or other testosterone supplements, contact us for more information about how to protect your rights to compensation for your injuries or vist us at www.androgellawyers.com.